Merello M, Esteguy M, Perazzo F, Leiguarda R
Fleni (Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia), Buenos Aires, Argentina.
Clin Neuropharmacol. 1992 Feb;15(1):69-74. doi: 10.1097/00002826-199202000-00010.
A patient with melanoma and sporadic positive melanuria developed Parkinson's disease. Treatment with levodopa failed to modify tumoral progress. However, during chemotherapy with dacarbazine, the patient experienced a significant impairment to levodopa response.
一名患有黑色素瘤且间歇性出现黑尿阳性的患者患上了帕金森病。左旋多巴治疗未能改变肿瘤进展。然而，在使用达卡巴嗪进行化疗期间，患者对左旋多巴的反应出现了显著损害。
